Immuron (IMRN) EBIT (2016 - 2025)
Immuron (IMRN) posted EBIT of -$3.4 million for Q2 2025, down 8754.84% on a QoQ basis from -$38654.9 in Q3 2024, and up 10.47% year-over-year from -$3.1 million in Q2 2024.
Powered by 
Analysis
Immuron (IMRN) EBIT (2016 - 2025) Analysis & Trends
Immuron has reported EBIT for 10 years, with the latest figure at -$3.4 million in Q2 2025.
- On a quarterly basis, EBIT rose 10.47% year-over-year to -$3.4 million in Q2 2025; TTM through Jun 2025 was -$9.6 million, a 24.15% decrease from a year earlier, with the FY2026 full-year figure at -$4.0 million, down 7350.01% from the prior year.
- EBIT was -$3.4 million for Q2 2025 at Immuron, down from -$38654.9 in the prior quarter.
- The five-year high for EBIT was -$13326.4 in Q4 2021, with the low at -$6.5 million in Q2 2021.
- Average EBIT over 5 years is -$2.2 million, with a median of -$1.8 million recorded in 2023.
- The sharpest annual moves came in 2021 and 2022: EBIT soared 68.22% in 2021, then tumbled 2546.58% in 2022.
- Over 5 years, EBIT stood at -$13326.4 in 2021, then sank by 2546.58% to -$352692.6 in 2022, then plunged by 558.73% to -$2.3 million in 2023, then jumped by 98.34% to -$38654.9 in 2024, then plunged by 8754.84% to -$3.4 million in 2025.
- The last three EBIT figures came in at -$3.4 million (Q2 2025), -$38654.9 (Q3 2024), and -$3.8 million (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 3.51 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -10.39 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 1.29 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 493.00 Mn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -815.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 231.44 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -644.50 Mn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -365.99 Mn |
| 10 | Immuron | 10.28 Mn | 1.26 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -3.42 Mn |
| Sep 9, 2024 | -38,654.88 |
| Jun 30, 2024 | -3.82 Mn |
| Dec 31, 2023 | -2.32 Mn |
| Jun 30, 2023 | -1.24 Mn |
| Dec 31, 2022 | -352,692.59 |
| Dec 31, 2021 | -13,326.36 |
| Jun 30, 2021 | -6.45 Mn |
| Dec 31, 2020 | -41,934.90 |
| Jun 30, 2020 | -1.90 Mn |
| Dec 31, 2019 | -15,191.40 |
| Dec 31, 2018 | -1.58 Mn |
| Dec 31, 2017 | 3.79 Mn |
| Dec 31, 2016 | 2.56 Mn |
| Jun 30, 2016 | 4.33 Mn |